NLOC-15A

N/A

Report date: 2026/05/08 20:02:52

NME

Base Information

Drug NameNLOC-15A

Drug Alias NameNLOC-15A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDual specificity mitogen-activated protein kinase kinase 1 inhibitorsSerine/threonine-protein kinase mTOR inhibitorsTranscriptional coactivator YAP1 inhibitors +[4]

TargetsEpidermal growth factor receptor erbB1Dual specificity mitogen-activated protein kinase kinase 1Serine/threonine-protein kinase mTOR +[4]

Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTaipei Medical University

China Registration ClassN/A

Develop Information

Active CompaniesTaipei Medical University

Inactive CompaniesN/A

Active IndicationsCarcinoma, Non-Small-Cell Lung

Inactive IndicationsN/A

Other Information

ATC CodeN/A